Monotherapy Trials of New Antiepileptic Drugs
- 1 September 1997
- Vol. 38 (s9), S21-S31
- https://doi.org/10.1111/j.1528-1157.1997.tb05201.x
Abstract
A number of clinical trials that test the efficacy and safety of the newer antiepileptic drugs (AEDs) have recently been concluded. Two dose-response trials in inpatients with refractory partial seizures and outpatients with newly diagnosed partial epilepsy established the efficacy of gabapentin as monotherapy. Lamotrigine was found to have efficacy similar to that of phenytoin and carbamazepine (CBZ) and to be better tolerated than CBZ in patients with newly diagnosed epilepsy. It was also shown to have efficacy as monotherapy in partial seizures, based on the results of an active controlled trial, and in the treatment of absence seizures, based on the results of a responder-enriched study. Topiramate as monotherapy was found to be efficacious for treatment of partial-onset seizures, based on the results of a single-center dose-response trial. A dose-response trial that tested the efficacy of tiagabine monotherapy in patients with refractory partial epilepsy was uninformative. Oxcarbazepine was found to be safe and efficacious in four comparative trials in patients with newly diagnosed epilepsy as well as in one placebo-controlled inpatient trial in patients with refractory partial seizures.Keywords
This publication has 10 references indexed in Scilit:
- Gabapentin monotherapy: II. A 26-week, double-blind, dose-controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizuresNeurology, 1997
- Gabapentin monotherapy: I. An 8-day, double-blind, dose controlled, multicenter study in hospitalized patients with refractory complex partial or secondarily generalized seizuresNeurology, 1997
- What Trials, Which Designs?Epilepsia, 1997
- Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosagesNeurology, 1996
- A double-blind, placebo-controlled study of Vigabatrin three g/day in patients with uncontrolled complex partial seizuresNeurology, 1996
- Gabapentin (Neurontin) as Add‐on Therapy in Patients with Partial Seizures: A Double‐Blind, Placebo‐Controlled StudyEpilepsia, 1994
- Gabapentin as add‐on therapy in refractory partial epilepsyNeurology, 1993
- Gabapentin in partial epilepsyThe Lancet, 1990
- Hazards of Inference: The Active Control InvestigationEpilepsia, 1989
- Government Viewpoint of Clinical TrialsDrug Information Journal, 1982